How Should We Evaluate Outcomes for Use of Biologics in the Knee?
THE JOURNAL OF KNEE SURGERY 2014
In recent years, the use of biologics for the primary treatment and augmentation of treatment in patients with knee pathology has increased substantially. Techniques and applications for biologic preparations such as platelet-rich plasma (PRP) and mesenchymal stem cells (MSCs) have been developed and redefined to increase the healing response in […]